MK-7602 Multiple Ascending Dose Study in Healthy Participants
Phase 1
- Conditions
- MalariaMedDRA version: 20.0Level: PTClassification code: 10025487Term: Malaria Class: 100000004862Therapeutic area: Diseases [C] - Parasitic Diseases [C03]
- Registration Number
- CTIS2023-503738-36-00
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method